Rigel to Present at the 2024 Cantor Global Healthcare Conference
Rigel Pharmaceuticals (Nasdaq: RIGL), a biotechnology company focused on hematologic disorders and cancer, announced its participation in the 2024 Cantor Global Healthcare Conference. CEO Raul Rodriguez will present a company overview on September 19, 2024, at 9:10 am ET in New York.
The presentation will be accessible via live webcast through Rigel's Investor Relations website. Founded in 1996 and based in South San Francisco, Rigel is dedicated to developing novel therapies for patients with hematologic disorders and cancer. Investors can access more information about Rigel's products and pipeline on their official website.
Rigel Pharmaceuticals (Nasdaq: RIGL), un'azienda biotech focalizzata sui disturbi ematologici e sul cancro, ha annunciato la sua partecipazione alla 2024 Cantor Global Healthcare Conference. Il CEO Raul Rodriguez presenterà una panoramica dell'azienda il 19 settembre 2024, alle 9:10 ET a New York.
La presentazione sarà accessibile tramite webcast dal vivo attraverso il sito web delle Relazioni con gli Investitori di Rigel. Fondata nel 1996 e con sede a South San Francisco, Rigel è dedicata allo sviluppo di terapie innovative per pazienti con disturbi ematologici e cancro. Gli investitori possono accedere a ulteriori informazioni sui prodotti e sul pipeline di Rigel sul loro sito ufficiale.
Rigel Pharmaceuticals (Nasdaq: RIGL), una empresa de biotecnología centrada en trastornos hematológicos y cáncer, anunció su participación en la 2024 Cantor Global Healthcare Conference. El CEO Raul Rodriguez presentará una visión general de la empresa el 19 de septiembre de 2024, a las 9:10 am ET en Nueva York.
La presentación será accesible a través de una transmisión web en vivo a través del sitio web de Relaciones con Inversores de Rigel. Fundada en 1996 y con sede en South San Francisco, Rigel se dedica a desarrollar terapias novedosas para pacientes con trastornos hematológicos y cáncer. Los inversores pueden acceder a más información sobre los productos y la línea de desarrollo de Rigel en su sitio web oficial.
리젤 제약 (Nasdaq: RIGL)은 혈액 장애 및 암에 집중하는 생명공학 회사로서 2024 칸토 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. CEO 라울 로드리게스는 2024년 9월 19일 오전 9시 10분 ET 뉴욕에서 회사 개요를 발표할 예정입니다.
발표는 리젤의 투자자 관계 웹사이트를 통해 실시간 웹캐스트로 접근할 수 있습니다. 1996년에 설립되어 샌프란시스코 남부에 본사를 둔 리젤은 혈액 장애 및 암 환자를 위한 혁신적인 치료법 개발에 전념하고 있습니다. 투자자는 리젤의 제품 및 파이프라인에 대한 추가 정보를 공식 웹사이트에서 확인할 수 있습니다.
Rigel Pharmaceuticals (Nasdaq: RIGL), une entreprise de biotechnologie axée sur les troubles hématologiques et le cancer, a annoncé sa participation à la 2024 Cantor Global Healthcare Conference. Le PDG Raul Rodriguez présentera un aperçu de l'entreprise le 19 septembre 2024 à 9h10 ET à New York.
La présentation sera accessible via un webcast en direct sur le site des relations investisseurs de Rigel. Fondée en 1996 et située à South San Francisco, Rigel se consacre au développement de thérapies novatrices pour les patients souffrant de troubles hématologiques et de cancer. Les investisseurs peuvent trouver plus d'informations sur les produits et le pipeline de Rigel sur leur site officiel.
Rigel Pharmaceuticals (Nasdaq: RIGL), ein biopharmazeutisches Unternehmen, das sich auf hämatologische Erkrankungen und Krebs konzentriert, hat seine Teilnahme an der 2024 Cantor Global Healthcare Conference bekannt gegeben. CEO Raul Rodriguez wird am 19. September 2024 um 9:10 Uhr ET in New York eine Unternehmensübersicht präsentieren.
Die Präsentation wird über einen Live-Webcast auf der Investor-Relations-Website von Rigel zugänglich sein. Gegründet im Jahr 1996 und mit Sitz in South San Francisco, widmet sich Rigel der Entwicklung neuartiger Therapien für Patienten mit hämatologischen Erkrankungen und Krebs. Investoren können weitere Informationen über Rigels Produkte und Pipeline auf der offiziellen Website abrufen.
- None.
- None.
To access the live webcast or archived recording, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in
Contact for Investors & Media:
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com
Media:
David Rosen
Argot Partners
212.600.1902
david.rosen@argotpartners.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-to-present-at-the-2024-cantor-global-healthcare-conference-302245905.html
SOURCE Rigel Pharmaceuticals, Inc.
FAQ
When is Rigel Pharmaceuticals presenting at the Cantor Global Healthcare Conference in 2024?
Who will be presenting for Rigel Pharmaceuticals at the 2024 Cantor Global Healthcare Conference?
How can investors access Rigel Pharmaceuticals' presentation at the 2024 Cantor conference?
What is the main focus of Rigel Pharmaceuticals (RIGL) as mentioned in the 2024 conference announcement?
Where is Rigel Pharmaceuticals (RIGL) headquartered according to the 2024 conference press release?
